Dr. David Martin’s Interview on Bloomberg (10/24/2012)

Date:  Thu, 2012-10-25

On May 6, 2011, M·CAM published a Patently Obvious™ Report on the “Intellectual Property Analysis of Apple Inc.’s U.S. Patent No. 7,469,381” Link: http://bit.ly/RVUTe1. This report called into question the enforceablilty of Apple’s ‘381 patent naming the same patent that M·CAM had identified – – U.S. Patent No. 7,786,975 [‘975], among others, as potentially uncited prior art. As reported in yesterday’s New York Times (http://nyti.ms/QXnlv8) and elsewhere, the U.S. Patent and Trademark Office has decided in an initial ruling that this patent should never have been granted, confirming the ‘975 patent as limiting prior art. “Claims 1-5, 9-13, and 15-20 are rejected under 35 U.S.C. 102(b) as being anticipated” by the ‘975 patent.

Last night, Dr. David Martin appeared on Bloomberg with Bloomberg West’s Cory Johnson. Dr. Martin and Mr. Johnson discussed the patent decision and what can be expected to unfold next in this smartphone war. See the video here: http://bloom.bg/VpIVdD

What does this mean? Using M·CAM’s proprietary financial underwriting systems, M·CAM was able to identify the precise prior art which may have an adverse impact on the appeal of the $1.05 Billion judgement. More amazingly, M·CAM was able to identify this a full 1.5 years before the judgement came in!

What does this mean for YOU? M·CAM’s risk management and underwriting systems can be deployed to identify uncorrelated information and measure the material impact it will likely have on the value of your current and anticipated investments. For more information, please contact us here: info@m-cam.com or 434-979-7240 or visit our website http://www.m-cam.com